Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil pre-injection with remimazolam for gynecological day surgery anesthesia
ChiCTR2200066640Phase 4Not yet recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and alfentanil in gynaecological conditions (4 arms), sponsored by Weifang People's Hospital. Primary endpoint: Induction dose of remimazolam. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
remimazolamalfentanil
03
Conditions
gynaecological conditions
Beyond the preview
Go deeper on ChiCTR2200066640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066640.